Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Avenue Therapeutics, Inc. (ATXI) had Weighted-Average Shares Outstanding (Diluted) of 3.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$1.40M |
|
$0.34M |
|
-- |
|
$1.40M |
|
$1.11M |
|
$0.30M |
|
$0.03M |
|
$0.33M |
|
$0.33M |
|
$0.33M |
|
$0.33M |
|
$0.33M |
|
$0.33M |
|
$0.30M |
|
$0.30M |
|
3.18M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
3.18M |
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$4.16M |
|
-- |
|
-- |
|
$4.16M |
|
$1.33M |
|
-- |
|
-- |
|
$1.33M |
|
$2.83M |
|
$2.83M |
|
$2.83M |
|
3.18M |
|
| Cash Flow Statement Financials | |
$-1.36M |
|
-- |
|
$2.09M |
|
$2.59M |
|
$3.33M |
|
$0.73M |
|
$0.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
21.15% |
|
21.15% |
|
-- |
|
23.43% |
|
23.86% |
|
$-1.36M |
|
-- |
|
-- |
|
-- |
|
0.34 |
|
-- |
|
1.75 |
|
51.28 |
|
11.62% |
|
11.62% |
|
7.91% |
|
11.62% |
|
$0.89 |
|
$-0.43 |
|
$-0.43 |
|